arrow
B

Brigitte Dréno

Nantes Universite
H指数:103
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study

兰瑞肽,一种生长抑素类似物,在晚期 Merkel 细胞癌中的应用:一项前瞻性单臂 II 期研究

2026-09-290
OAAI
Real-World Use of Adjuvant Nivolumab for Resected Stage III–IV Melanoma: 2-Year Analysis of AdjuMel

辅助尼洛替尼用于切除后的III-IV期黑色素瘤的实-world应用:AdjuMel 2年分析

2026-08-290
OAAI
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026

欧洲共识性多学科指南:侵袭性皮肤鳞状细胞癌。第一部分:诊断与预防 - 2026年更新

2026-05-070
OAAI
Update of the EuroGuiDerm evidence-based guideline for the treatment of acne—Short version

《EuroGuiDerm基于证据的痤疮治疗指南更新——简版》

2026-03-180
OAAI
Messages for ultraviolet-radiation protection to fair-skinned populations

关于紫外线防护的信息,面向肤色较浅的人群

2025-11-060
OAAI
PIGMENTARY DISORDERS AROUND THE WORLD: SELF-REPORTED PREVALENCE AND IMPACT ON QUALITY OF LIFE AND SOCIAL STIGMATIZATION

全球色素性疾病:自报患病率以及对生活质量和社会污名化的影响

2025-11-050
PRE
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas

免疫检查点抑制剂作为肢端黑色素瘤辅助治疗的优势

2025-11-010
OAAI
Performance of a Deep Learning Algorithm for Melanoma Classification Across Diverse Dermoscopic and Tele-Dermatology Datasets

基于深度学习算法的黑色素瘤分类性能:跨多样化皮肤镜和远程皮肤病学数据集研究

2025-10-010
OAAI
Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

晚期 Merkel 细胞癌患者生存结局及对免疫检查点抑制剂的应答:一项包含 81 例患者的回顾性研究

2025-08-020
PRE
Inter- and intra-observer agreement among dermatologists in assessing suspected melanoma lesions captured by general practitioners with smartphones

皮肤科医生在评估全科医生使用智能手机拍摄的疑似黑色素瘤病灶时的观察者间和观察者内一致性

2025-05-140
PRE